Attached files
| file | filename |
|---|---|
| EX-99.1 - TRANSCRIPT - SIGA TECHNOLOGIES INC | kl12015_ex99-1.htm |
| EX-99.2 - PRESS RELEASE - SIGA TECHNOLOGIES INC | kl12015_ex99-2.htm |
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15 (d) OF
THE
SECURITIES EXCHANGE ACT OF 1934
Date of
Report (Date of earliest event reported): December 14,
2009
SIGA
TECHNOLOGIES, INC.
(Exact
name of registrant as specified in its charter)
|
Delaware
|
0-23047
|
13-3864870
|
|
(State
or other jurisdiction of
incorporation
or organization)
|
(Commission
file number)
|
(I.R.S.
employer
identification
no.)
|
|
420
Lexington Avenue,
Suite
408
New
York, New York
(Address
of principal executive offices)
|
10170
(Zip
code)
|
Registrant’s
telephone number, including area code: (212) 672-9100
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General
Instruction A.2. below):
| r |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
| r |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
| r |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
| r |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item
7.01. Regulation FD
Disclosure.
On
December 14, 2009, SIGA Technologies, Inc. (the “Company”) hosted a conference
call for investors to discuss the Biomedical Advanced Research & Development
Authority’s (BARDA) amendment to the outstanding Request for Proposal for
Smallpox Antiviral for The Strategic National Stockpile (RFP-BARDA-09-35).
Attached as Exhibit 99.1 to this Current Report on Form 8-K is a transcript of
such call. Any information contained in this transcript should be read in the
context of and with due regard to the more detailed information provided in
other documents we file with or furnish to the Securities and Exchange
Commission (the “Commission”).
The
information set forth in this Item 7.01 and the attached Exhibit 99.1 is
furnished to, but shall not be deemed “filed” with, the Commission for the
purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the
“Exchange Act”), or otherwise incorporated by reference into any filing pursuant
to the Securities Act of 1933, as amended, or the Exchange Act, except as
otherwise expressly stated in such a filing.
Item
8.01. Other
Events.
On
December 14, 2009, the Company issued a press release announcing the closing of
its previously announced offering of 2,725,339 shares of its common stock, par
value $0.0001 per share, at a purchase price of $7.35 per share. A
copy of the press release announcing the closing of the offering is attached as
Exhibit 99.2 hereto.
|
(d)
|
Exhibits
|
|
Exhibit No.
|
Description
|
|
99.1
|
Transcript
of December 14, 2009 Investor Conference Call
|
| 99.2 | Press Release, dated December 14, 2009 |
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
SIGA TECHNOLOGIES,
INC.
By: /s/ Ayelet
Dugary
Ayelet
Dugary
Chief
Financial Officer
Date: December
14, 2009